Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 675 of 1048 entries
View as:

Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00710164 Org: User:
Start: 09/30/08 End: - Due: -

An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06517004 Org: User:
Start: 07/18/24 End: 08/31/27 Due: 08/31/28

A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT06682117 Org: User:
Start: 11/15/24 End: 09/30/25 Due: 09/30/26

The Effective Effect-Site Propofol Concentration for Induction and Intubation for Schnider Model in Parturients

Phase: N/A Priority: Normal
NCT ID: NCT02554175 Org: User:
Start: 10/31/15 End: 12/31/17 Due: 12/31/18

Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06313554 Org: User:
Start: 05/20/24 End: 05/20/27 Due: 05/20/28

Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT02631564 Org: User:
Start: 06/30/15 End: 12/31/18 Due: 12/31/19

Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)

Phase: N/A Priority: Normal
NCT ID: NCT05823987 Org: User:
Start: 05/16/23 End: 12/30/25 Due: 12/30/26

Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT03241888 Org: User:
Start: 07/04/17 End: 06/18/20 Due: 06/18/21

Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05086614 Org: User:
Start: 04/01/21 End: 03/31/27 Due: 03/31/28

Selective Neck Dissection Versus Modified Neck Dissection in PTC

Phase: N/A Priority: Normal
NCT ID: NCT06554652 Org: User:
Start: 09/01/24 End: 06/30/29 Due: 06/30/30

PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)

Phase: N/A Priority: Normal
NCT ID: NCT03244566 Org: User:
Start: 06/26/18 End: 07/01/21 Due: 07/01/22

a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT05670691 Org: User:
Start: 01/10/23 End: 03/01/25 Due: 03/01/26

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Phase: N/A Priority: Normal
NCT ID: NCT02631499 Org: User:
Start: 12/31/15 End: 12/31/19 Due: 12/31/20

Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC

Phase: N/A Priority: Normal
NCT ID: NCT00601159 Org: User:
Start: 09/30/07 End: 09/30/10 Due: 09/30/11

Titration of Intraoperative PEEP in Patients Undergoing Robotic Assisted Laparoscopic Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT05155371 Org: User:
Start: 10/20/21 End: 01/20/23 Due: 01/20/24

UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03824899 Org: User:
Start: 10/10/18 End: 05/31/20 Due: 05/31/21

Esophagectomy: Sweet Versus Ivor-Lewis (ESVIL) (ECTOP-2001)

Phase: N/A Priority: Normal
NCT ID: NCT01047111 Org: User:
Start: 05/31/10 End: 07/31/17 Due: 07/31/18

Lenvatinib Combined With TACE to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03838796 Org: User:
Start: 01/03/19 End: 06/30/23 Due: 06/30/24

Transanual Tube Placement in Low Anterior Resection (LAR) for Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02905968 Org: User:
Start: 01/31/16 End: 12/31/18 Due: 12/31/19

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04612894 Org: User:
Start: 12/01/20 End: 12/31/23 Due: 12/31/24

A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS

Phase: N/A Priority: Normal
NCT ID: NCT06545994 Org: User:
Start: 06/28/24 End: 06/30/26 Due: 06/30/27

FSRT in Breast Cancer Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04061408 Org: User:
Start: 07/01/19 End: 07/31/22 Due: 07/31/23

Effectiveness of Gut Microbiota-targeted Dietary Intervention Among HIV-infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT06279819 Org: User:
Start: 03/01/24 End: 12/31/24 Due: 12/31/25

Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC

Phase: N/A Priority: Normal
NCT ID: NCT06010888 Org: User:
Start: 10/31/23 End: 03/31/26 Due: 03/31/27

The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites

Phase: N/A Priority: Normal
NCT ID: NCT02779608 Org: User:
Start: 01/20/17 End: 06/30/18 Due: 06/30/19